Publication | Closed Access
Norcantharidin potentiates sorafenib antitumor activity in hepatocellular carcinoma rat model through inhibiting IL-6/STAT3 pathway
36
Citations
66
References
2023
Year
Il-6/stat3 PathwayMedicineOncogenic AgentImmunologyPharmacologyAnti-cancer AgentOncologySorafenib Antitumor ActivityHepatocellular CarcinomaCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1